The Treatment of Superficial Femoral Artery In-Stent Restenosis: The Jury Is Still Out ∗

JACC: Cardiovascular Interventions

Volumn 9, Issue 13, 2016, Pages 1393-1396

  Gray, Bruce H ^a   Buchan, Jack A ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

Author keywords

drug coated balloon; in stent restenosis; superficial femoral artery

Indexed keywords

POLITEF;

ANTICOAGULATION; AORTA BALLOON; ARTERY PROSTHESIS; BARE METAL STENT; BYPASS SURGERY; CARDIOVASCULAR RISK; CLAUDICATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY RECANALIZATION; DOPPLER ECHOCARDIOGRAPHY; DRUG COATED BALLOON; DRUG ELUTING STENT; EDITORIAL; EXCIMER LASER; HUMAN; IN-STENT RESTENOSIS; PACLITAXEL ELUTING CORONARY STENT; PATIENT COMPLIANCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK FACTOR; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY IN STENT RESTENOSIS; THROMBOSIS; TIME TO TREATMENT; VASCULAR PATENCY; FEMORAL ARTERY; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; CONSTRICTION, PATHOLOGIC; FEMORAL ARTERY; HUMANS; STENTS; TREATMENT OUTCOME;

EID: 84990845554     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.04.029     Document Type: Editorial

References (8)

1. 1 Kinstner, C.M., Lammer, J., Willfort-Ehringer, A., et al. Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial. J Am Coll Cardiol Intv 9 (2016), 1386–1392.
2. 2 Bosiers, M., Deloose, K., Callaert, J., et al. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve month results from a multicenter randomized trial. J Endovasc Ther 22 (2015), 1–10.
3. 3 Dippel, E.J., Makam, P., Kovach, R., et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCimer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). J Am Coll Cardiol Intv 8 (2015), 92–101.
4. 4 Krankenberg, H., Tubler, T., Ingwersen, M., et al. Drug-coated balloon versus standard balloon for superficial femoral artery in –stent restenosis: the Randomized Femoral Artery In-Stent Restenosis (FAIR) trial. Circulation 132 (2015), 2230–2236.
5. 5 Tosaka, A., Soga, Y., Iida, O., et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 59 (2012), 16–23.
6. 6 Zeller, T., Dake, M.D., Tepe, G., et al. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. J Am Coll Cardiol Intv 6 (2013), 274–281.
7. 7 Trentmann, J., Charalambous, N., Djawanscher, M., et al. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg 51 (2010), 551–560.
8. 8 Shin, S.H., Baril, D.T., Chaer, R.A., et al. Cryoplasty offers no advantage over standard balloon angioplasty for the treatment of in-stent stenosis. J Vasc Surg 52 (2010), 803–804.